Mouse Infection Protocol
Mouse Infection Protocol - Related Videos
15:25
Protocol for Dengue Infections in Mosquitoes (A. aegypti) and Infection Phenotype Determination
0 Views •
Cited by 35 •
2007
Once a gene is identified as potentially refractory for the dengue virus, it must be evaluated for it's role in preventing viral infections within the mosquito. This protocol illustrates how the extent of dengue infections of mosquitoes can be assayed. The techniques for growing up the virus in culture, membrane feeding mosquitoes human blood, and assaying viral titers in the mosquito midgut are demonstrated.
09:01
Chronic Salmonella Infected Mouse Model
0 Views •
Cited by 12 •
2010
Establish a chronic bacterial infected mouse model with persistent Salmonella typhimurium colonization in intestine for 27 weeks.
14:10
Protocol for Plasmodium falciparum Infections in Mosquitoes and Infection Phenotype Determination
0 Views •
Cited by 9 •
2007
Once a gene is identified as potentially refractory for malaria, it must be evaluated for its role in preventing Plasmodium infections within the mosquito. This protocol illustrates how the extent of plasmodium infections of mosquitoes can be assayed. The techniques for preparing the gametocyte culture, membrane feeding mosquitoes human blood, and assaying viral titers in the mosquito midgut are demonstrated.
06:50
A Protocol to Infect Caenorhabditis elegans with Salmonella typhimurium
0 Views •
Cited by 1 •
2014
C. elegans has emerged as a new genetic model to study host-pathogen interactions. Here we describe a protocol to infect C. elegans with Salmonella typhimurium coupled with the double-strand RNAi interference technique to examine the role of host genes in defense against Salmonella infection.
10:44
Influenza A Virus Studies in a Mouse Model of Infection
0 Views •
Cited by 38 •
2017
Influenza A viruses (IAVs) are important human respiratory pathogens. To understand the pathogenicity of IAVs and to perform preclinical testing of novel vaccine approaches, animal models mimicking human physiology are required. Here, we describe techniques to evaluate IAV pathogenesis, humoral responses and vaccine efficacy using a mouse model of infection.
FAQs
The inoculation route, dose, and timing establish the conditions under which infection and disease are evaluated. Keeping these variables defined and controlled helps researchers compare clinical observations, pathogen measurements, tissue findings, and immune responses across experimental groups. Their careful specification also supports reproducibility when studying disease progression or testing interventions.
Disease outcomes reflect an interaction between microbial virulence and the host immune response rather than either factor alone. Measuring pathogen levels alongside tissue changes and immune readouts helps investigators examine how infection progresses and how the host responds. This combined view supports biological interpretation of host-pathogen interactions and treatment effects.
Defined animal-monitoring criteria provide a structured way to track clinical changes during the study. When combined with pathogen measurements, tissue analysis, and immune readouts, these observations help relate visible disease to underlying biological processes. Monitoring also incorporates animal-welfare considerations, making the experimental design more responsible and the recorded outcomes more consistent.
A protocol first specifies the infectious agent and experimental conditions, including inoculation route, dose, and timing. Researchers then monitor the animals according to defined criteria and collect evidence through clinical observations, pathogen measurements, tissue analysis, and immune readouts. The resulting data are used to evaluate disease, host responses, or treatment effects under controlled conditions.
Assessment can combine several complementary outcome types: clinical observations describe disease-related changes, pathogen measurements indicate the infectious burden being examined, tissue analysis reveals effects within organs or other sampled material, and immune readouts characterize host responses. Using these measures together provides a broader assessment than relying on a single indicator of infection.
These studies are useful for investigating host-pathogen interactions, linking microbial virulence with disease progression, and evaluating how hosts respond to infection. They also support vaccine development and antimicrobial testing by providing a controlled biological setting for examining treatment effects. Appropriate containment, animal-welfare practices, and experimental design remain essential to their use.